Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection

Publication date

2020-11-12T09:47:39Z

2020-11-12T09:47:39Z

2019-04-01

2020-11-12T09:47:39Z

Abstract

Poly(propylene imine) dendrimers have been shown to be promising 3-dimensional polymers for the use in the pharmaceutical andbiomedical applications. Our aims of this study were first, to synthesize a novel type of dendrimer with poly(propylene imine) core andmaltose-histidine shell (G4HisMal) assessing if maltose-histidine shell can improve the biocompatibility and the ability to cross the blood-brain barrier, and second, to investigate the potential of G4HisMal to protect Alzheimer disease transgenic mice from memory impairment.Our data demonstrate that G4HisMal has significantly improved biocompatibility and ability to cross the blood-brain barrier in vivo.Therefore, we suggest that a maltose-histidine shell can be used to improve biocompatibility and ability to cross the blood-brain barrier ofdendrimers. Moreover, G4HisMal demonstrated properties for synapse and memory protection when administered to Alzheimer diseasetransgenic mice. Therefore, G4HisMal can be considered as a promising drug candidate to prevent Alzheimer disease via synapse protection1

Document Type

Article


Published version

Language

English

Publisher

Future Medicine

Related items

Reproducció del document publicat a: https://doi.org/10.1016/j.nano.2019.01.010

Nanomedicine, 2019, vol. 17, p. 198-209

https://doi.org/10.1016/j.nano.2019.01.010

Recommended citation

This citation was generated automatically.

Rights

CC-BY (c) Future Medicine, 2019

http://creativecommons.org/licenses/by-cc-by/3.0/